nuclear phase-out policy
Scope
Date
~
-
North Korea
Top US general sees changing nuclear threat from North Korea
COMMAND POST TANGO, South Korea—The top U.S. military official in South Korea said his thinking has changed on deterring North Korea’s n...
Mar 20, 2024 (Gmt+09:00)
-
Artificial intelligence
Lunit gets court approval for Volpara acquisition in New Zealand
South Korean medical AI company Lunit announced on Thursday that it received the first approval from the High Court of New Zealand for its plan to a...
Mar 14, 2024 (Gmt+09:00)
-
Energy
LS Eco Energy to supply UHV cables to Singapore's EMA
South Korea's LS Eco Energy Ltd. announced on Tuesday that its Vietnamese production subsidiary, LS-VINA, will supply 12 billion won ($8.99 million)...
Mar 05, 2024 (Gmt+09:00)
-
North Korea
While the World Was Looking Elsewhere, North Korea Became a Bigger Threat
SEOUL—In March 2022, North Korean leader Kim Jong Un walked out of a massive hangar wearing a bomber jacket and dark sunglasses. He pointed to t...
Feb 27, 2024 (Gmt+09:00)
-
Energy
KHNP, Centrus sign LOI for nuclear fuel supply
Korea Hydro & Nuclear Power Co. (KHNP) announced on Monday that it has signed a letter of intent (LOI) with the US-based Centrus Energy Corp. to...
Feb 27, 2024 (Gmt+09:00)
-
Energy
Hyundai E&C likely to win Bulgaria’s nuclear project
South Korea’s Hyundai Engineering & Construction Co. (Hyundai E&C) was picked as the preferred bidder for Bulgaria's new nuclear react...
Feb 26, 2024 (Gmt+09:00)
-
Short selling
Korean stock market volatility up since short-selling ban
The South Korean stock market has seen increased volatility and few rallies over the past three months, in sharp contrast to government hopes that i...
Feb 13, 2024 (Gmt+09:00)
-
Korean stock market
Hyundai Department stocks down on cheap dividend policy
Hyundai Department Store Group, a South Korean major retail conglomerate, has unveiled the group companies’ dividend payout plans for the mid ...
Feb 08, 2024 (Gmt+09:00)
-
Bio & Pharma
Aprogen gets OK Phase 3 trials in India for Herceptin biosimilar
South Korea’s biopharmaceutical company Aprogen Inc. announced on Monday that its Phase 3 clinical trial for a biosimilar of Herceptin (trastu...
Feb 05, 2024 (Gmt+09:00)
-
Energy
HD KSOE seeks to build nuclear power plant ships
HD Korea Shipbuilding & Offshore Engineering Co. (HD KSOE) is hastening to advance into the nuclear power plant ship market in collaboration wit...
Feb 04, 2024 (Gmt+09:00)
-
Economy
Korea’s inflation at 6-month low in further relief to BOK
South Korea’s headline inflation dropped for a third straight month to a six-month low on declining oil prices, adding relief to the central b...
Feb 02, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem to start phase 3 for head, neck cancer drug in US
South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...
Jan 17, 2024 (Gmt+09:00)
-
Bio & Pharma
JW Pharma takes gout drug Epaminurad to Malaysia for phase 3
South Korea's JW Pharmaceutical Corp., announced on Monday that it has received approval from the Malaysian National Pharmaceutical Regulatory Age...
Jan 15, 2024 (Gmt+09:00)
-
Central bank
BOK hints at policy rate peak but in no hurry to cut rates
South Korea’s central bank on Thursday hinted its policy rate may have peaked after leaving the rate unchanged for the eighth straight meeting...
Jan 11, 2024 (Gmt+09:00)
-
Foreign exchange
Koreans’ yen savings snap growth streak despite BOJ exit talk
Yen-denominated deposits in South Korea slid for the first time in eight months as local investors took profits from the recent gains in the major c...
Jan 10, 2024 (Gmt+09:00)
-
Korean stock market
S.Korea launches official probe into HSCEI-tied ELS sale
South Korea’s financial authorities have opened an official probe into local banks and securities firms’ potential misselling of equity-...
Jan 08, 2024 (Gmt+09:00)
-
Bio & Pharma
LG Chem out-licenses obesity drug candidate to US firm
LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...
Jan 05, 2024 (Gmt+09:00)
-
Bio & Pharma
MedPacto gets FDA OK for colorectal cancer drug clinical trial
South Korea's biotech company MedPacto Inc. announced on Tuesday that it has got approval from the US Food and Drug Administration (FDA) for its I...
Jan 03, 2024 (Gmt+09:00)
-
Retail
Korea’s Gmarket poised to post 1st profit since Shinsegae’s takeover
Gmarket, a major e-commerce website based in South Korea, likely turned to profit in the fourth quarter of last year, which would mark the first tim...
Jan 02, 2024 (Gmt+09:00)
-
Electric vehicles
Hyundai's Kona included on French EV subsidy eligibility list
Hyundai Motor Co.'s sports utility vehicle Kona is the only Korean EV included on a list of 78 electric vehicle models eligible for French subsidies...
Dec 15, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...
Dec 11, 2023 (Gmt+09:00)
-
Energy
KHNP eyes Canada's nuclear energy project with ARC, NB Power
Korea Hydro and Nuclear Power Co. (KHNP) said on Wednesday it has signed a non-binding agreement with ARC Clean Technology Canada Inc. and New Bruns...
Nov 29, 2023 (Gmt+09:00)
-
Automobiles
Car sales may sputter in 2024 amid EV policy risk: Research
The global automobile market is on track to recover to pre-pandemic levels this year and is expected to grow at a moderate pace amid a prolonged eco...
Nov 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Business & Politics
S.Korea-UK upgrade bilateral ties, sign deals on nuclear plants, chips
LONDON – South Korea and the UK have agreed to upgrade their bilateral relationship and closely cooperate in the defense, security and busines...
Nov 22, 2023 (Gmt+09:00)
-
Aerospace & Defense
Hyundai Wia to defend against illegal drones
South Korea's second-largest automotive parts supplier Hyundai Wia Corp. plans to develop an anti-drone system (ADS) technology tailored to the uniq...
Nov 16, 2023 (Gmt+09:00)
-
Energy
Hanwha’s REC Silicon plant restarts as US-China tension eases
REC Silicon ASA, a US-based polysilicon maker, in which Hanwha Solutions Corp. and its affiliate have a 33% stake, has restarted operations after a ...
Nov 16, 2023 (Gmt+09:00)
-
Energy
Doosan Enerbility secures contract for cask design from KHNP
South Korea's Doosan Enerbility Co. announced on Thursday it secured a contract for dry storage systems of spent nuclear fuel comprehensive design s...
Nov 02, 2023 (Gmt+09:00)
-
Energy
KHNP submits final bid for Czech Republic’s new nuclear power unit
Korea Hydro & Nuclear Power Co. (KHNP) has submitted a final bid to the Czech Republic’s state-run Elektrarna Dukovany II (EDU II) to cons...
Nov 01, 2023 (Gmt+09:00)
-
Bio & Pharma
NKMax to perform first tests on dementia cell therapy in US
NKMax Co., South Korea's largest developer of natural killer (NK) cell therapies, will conduct its first clinical trials in the US for its candidate...
Oct 26, 2023 (Gmt+09:00)